Any feedback?
Literature summary for 2.4.2.1 extracted from
- TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice (2006), J. Clin. Invest., 116, 2717-2726.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | trans-activator of transcription-mediated long-term intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice | Homo sapiens |
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
| trans-activator of transcription-mediated long-term intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice | Homo sapiens |
Localization
| Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | P00491 | - |
- |
Purification (Commentary)
| Purification (Comment) | Organism |
|---|---|
| recombinant | Homo sapiens |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| inosine + phosphate | - |
Homo sapiens | hypoxanthine + alpha-D-ribose 1-phosphate | - |
? |  |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
